Vimarsana
Biggest News Aggregation in the World

Diego Megia News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Diego Megia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Diego Megia Today - Breaking & Trending Today

People: UBS rejigs EQD, risk head departs; Rustad joins buy side, and more - Vimarsana News

People: UBS rejigs EQD, risk head departs; Rustad joins buy side, and more

Latest job changes across the industry

Source: risk.net
Hedge funds are hiring Goldman Sachs' rates traders before bonuses - Vimarsana News

Hedge funds are hiring Goldman Sachs' rates traders before bonuses

There were some big departures over Christmas.

Rustad re-emerges at Taula Capital - Vimarsana News

Rustad re-emerges at Taula Capital

Former JP Morgan clearing head to help prepare for Q2 fund launch

Source: risk.net
Morning Coffee: The British ex-Goldman Sachs partner profiting from David Solomon's mistakes. Bank cuts jobs before bonuses - Vimarsana News

Morning Coffee: The British ex-Goldman Sachs partner profiting from David Solomon's mistakes. Bank cuts jobs before bonuses

How to leave Goldman Sachs and thrive.

The Prostate Cancer Foundation And Cancer Research Innovation In Science Announce 2020 Young Investigator Award Winners - Vimarsana News

The Prostate Cancer Foundation And Cancer Research Innovation In Science Announce 2020 Young Investigator Award Winners

The Prostate Cancer Foundation And Cancer Research Innovation In Science Announce 2020 Young Investigator Award Winners News provided by Share this article Share this article LOS ANGELES, Dec. 16, 2020 /PRNewswire/ -- The Prostate Cancer Foundation (PCF) and Cancer Research Innovation in Science (CRIS) today announced two new CRIS Cancer Foundation-PCF Young Investigator Awards. The awards, each in the amount of $250,000, are granted to future research leaders at two of the United Kingdom's leading cancer research institutions who will keep the field of prostate cancer research vibrant with ...